Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival.

Al-Keilani, Maha S; Bdeir, Roba; Elstaty, Rana I; Alqudah, Mohammad A

Al-Keilani, Maha S; Bdeir, Roba; Elstaty, Rana I; Alqudah, Mohammad A.

Afiliação

Al-Keilani MS; College of Pharmacy, Department of Clinical Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, 22110, Irbid, Jordan. mskeilani@just.edu.jo.
Bdeir R; College of Nursing, Department of Allied Health Sciences, Al-Balqa Applied University, Al-Salt 19117, P.O. Box 206, Salt, Jordan.
Elstaty RI; College of Science and Art, Department of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, P.O. Box 3030, 22110, Irbid, Jordan.
Alqudah MA; College of Medicine, Department of Microbiology, Pathology, and Forensic Medicine, The Hashemite University, P.O. Box 330127, 13133, Zarqa, Jordan.

BMC Cancer ; 23(1): 158, 2023 Feb 16.

Article em En | MEDLINE | ID: mdl-36797689

Assuntos

Neoplasias da Mama; Neoplasias de Mama Triplo Negativas; Humanos; Feminino; Neoplasias da Mama/patologia; Substância P; Receptores da Neurocinina-1/metabolismo; Antígeno Ki-67/metabolismo; Piruvato Quinase; Hormônios; Microambiente Tumoral

Palavras-chave

Biomarker; Breast cancer; Invasive ductal carcinoma; Ki-67; Neurokinin 1 receptor; Prognosis; Proliferation index; Pyruvate kinase M2; Substance P

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Jordânia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google